secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kezar Life Sciences, Inc. (KZR)
CIK:        0001645666
Form:       8-K
Filed at:   2024-06-21T23:59:59+00:00
Accession:  0000950170-24-076234
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Kezar Life Sciences stockholders reject Say-on-Pay, approve reverse split authorization
--------------------------------------------------------------------------------

- Say-on-Pay advisory vote failed: 27.2M against vs 19.8M for.
- Reverse stock split authorized (ratio 1:2 to 1:20) at Board's discretion.
- Directors Christopher Kirk and John Fowler elected with >33M votes each.
- KPMG ratified as independent auditor for FY2024 with overwhelming support.
- Company will hold annual Say-on-Pay votes until 2030 after advisory vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645666/000095017024076234/0000950170-24-076234-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645666/000095017024076234/kzr-20240618.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-076234

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer